Published in J Control Release on July 08, 2011
Nuts and bolts of chemical exchange saturation transfer MRI. NMR Biomed (2013) 1.88
Monitoring enzyme activity using a diamagnetic chemical exchange saturation transfer magnetic resonance imaging contrast agent. J Am Chem Soc (2011) 1.41
Development of manganese-based nanoparticles as contrast probes for magnetic resonance imaging. Theranostics (2012) 1.09
MRI biosensor for protein kinase A encoded by a single synthetic gene. Magn Reson Med (2012) 1.07
Stimuli-responsive theragrippers for chemomechanical controlled release. Angew Chem Int Ed Engl (2014) 0.95
Human protamine-1 as an MRI reporter gene based on chemical exchange. ACS Chem Biol (2013) 0.95
Building bridges: leveraging interdisciplinary collaborations in the development of biomaterials to meet clinical needs. Adv Mater (2012) 0.84
The use of porous scaffold as a tumor model. Int J Biomater (2013) 0.77
Pre- and postmortem imaging of transplanted cells. Int J Nanomedicine (2015) 0.76
The Emerging Role of Nanotechnology in Cell and Organ Transplantation. Transplantation (2016) 0.75
Porosity of 3D biomaterial scaffolds and osteogenesis. Biomaterials (2005) 7.55
Using the amide proton signals of intracellular proteins and peptides to detect pH effects in MRI. Nat Med (2003) 6.57
Ultra-large-scale syntheses of monodisperse nanocrystals. Nat Mater (2004) 6.19
Strategies for increasing the sensitivity of gadolinium based MRI contrast agents. Chem Soc Rev (2006) 4.27
Artificial reporter gene providing MRI contrast based on proton exchange. Nat Biotechnol (2007) 3.87
Water saturation shift referencing (WASSR) for chemical exchange saturation transfer (CEST) experiments. Magn Reson Med (2009) 3.57
Chemical exchange saturation transfer contrast agents for magnetic resonance imaging. Annu Rev Biomed Eng (2008) 3.53
New "multicolor" polypeptide diamagnetic chemical exchange saturation transfer (DIACEST) contrast agents for MRI. Magn Reson Med (2008) 2.48
Biodegradable polymer scaffolds for tissue engineering. Biotechnology (N Y) (1994) 2.47
Chitosan-based hydrogels for controlled, localized drug delivery. Adv Drug Deliv Rev (2009) 2.25
Multifunctional uniform nanoparticles composed of a magnetite nanocrystal core and a mesoporous silica shell for magnetic resonance and fluorescence imaging and for drug delivery. Angew Chem Int Ed Engl (2008) 2.21
Development of a T1 contrast agent for magnetic resonance imaging using MnO nanoparticles. Angew Chem Int Ed Engl (2007) 2.19
Controlled release of functional proteins through designer self-assembling peptide nanofiber hydrogel scaffold. Proc Natl Acad Sci U S A (2009) 1.98
Injectable matrices and scaffolds for drug delivery in tissue engineering. Adv Drug Deliv Rev (2007) 1.97
New materials for tissue engineering: towards greater control over the biological response. Trends Biotechnol (2008) 1.69
High-throughput screening of chemical exchange saturation transfer MR contrast agents. Contrast Media Mol Imaging (2010) 1.59
Uniform mesoporous dye-doped silica nanoparticles decorated with multiple magnetite nanocrystals for simultaneous enhanced magnetic resonance imaging, fluorescence imaging, and drug delivery. J Am Chem Soc (2010) 1.58
Photocrosslinking characteristics and mechanical properties of diethyl fumarate/poly(propylene fumarate) biomaterials. Biomaterials (2002) 1.52
Effect of initial cell seeding density on early osteogenic signal expression of rat bone marrow stromal cells cultured on cross-linked poly(propylene fumarate) disks. Biomacromolecules (2009) 1.48
MR tracking of transplanted cells with "positive contrast" using manganese oxide nanoparticles. Magn Reson Med (2008) 1.46
Cartilage-like tissue engineering using silk scaffolds and mesenchymal stem cells. Tissue Eng (2006) 1.45
Salt fusion: an approach to improve pore interconnectivity within tissue engineering scaffolds. Tissue Eng (2002) 1.33
Soft and hard tissue response to photocrosslinked poly(propylene fumarate) scaffolds in a rabbit model. J Biomed Mater Res (2002) 1.31
Engineered bone development from a pre-osteoblast cell line on three-dimensional scaffolds. Tissue Eng (2000) 1.23
Issues in long-term protein delivery using biodegradable microparticles. J Control Release (2010) 1.21
Synthesis of poly(propylene fumarate). Nat Protoc (2009) 1.20
Engineering retinal progenitor cell and scrollable poly(glycerol-sebacate) composites for expansion and subretinal transplantation. Biomaterials (2009) 1.18
Early osteogenic signal expression of rat bone marrow stromal cells is influenced by both hydroxyapatite nanoparticle content and initial cell seeding density in biodegradable nanocomposite scaffolds. Acta Biomater (2010) 1.05
Photoinitiated cross-linking of the biodegradable polyester poly(propylene fumarate). Part II. In vitro degradation. Biomacromolecules (2003) 1.05
A biodegradable composite scaffold for cell transplantation. J Orthop Res (2002) 1.04
Stereolithographic bone scaffold design parameters: osteogenic differentiation and signal expression. Tissue Eng Part B Rev (2010) 1.03
Temperature-sensitive liposomes for doxorubicin delivery under MRI guidance. J Control Release (2009) 1.02
Controlled release of neurotrophin-3 from fibrin-based tissue engineering scaffolds enhances neural fiber sprouting following subacute spinal cord injury. Biotechnol Bioeng (2009) 1.01
Biodegradable polymeric scaffolds. Improvements in bone tissue engineering through controlled drug delivery. Adv Biochem Eng Biotechnol (2006) 0.98
Bone formation in transforming growth factor beta-1-coated porous poly(propylene fumarate) scaffolds. J Biomed Mater Res (2002) 0.98
Local delivery of a collagen-binding FGF-1 chimera to smooth muscle cells in collagen scaffolds for vascular tissue engineering. Biomaterials (2009) 0.94
Monitoring of release of cargo from nanocarriers by MRI/MR spectroscopy (MRS): significance of T2/T2* effect of iron particles. Magn Reson Med (2009) 0.92
Nanoparticle technology in bone tissue engineering. J Drug Target (2007) 0.90
Growth, differentiation, transplantation and survival of human skeletal myofibers on biodegradable scaffolds. Biomaterials (2008) 0.89
Calcium alginate beads embedded in silk fibroin as 3D dual drug releasing scaffolds. Biomaterials (2009) 0.88
Novel mesoporous silica-based antibiotic releasing scaffold for bone repair. Acta Biomater (2009) 0.87
Design and fabrication of 3D porous scaffolds to facilitate cell-based gene therapy. Tissue Eng Part A (2008) 0.84
Functionally gradient chitosan/hydroxyapatite composite scaffolds for controlled drug release. J Biomed Mater Res B Appl Biomater (2009) 0.84
Porous keratin scaffold-promising biomaterial for tissue engineering and drug delivery. J Biomed Mater Res B Appl Biomater (2010) 0.83
The drug release study of ceftriaxone from porous hydroxyapatite scaffolds. AAPS PharmSciTech (2009) 0.80
A protein/antibiotic releasing poly(lactic-co-glycolic acid)/lecithin scaffold for bone repair applications. Int J Pharm (2009) 0.78
Ultra-large-scale syntheses of monodisperse nanocrystals. Nat Mater (2004) 6.19
Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. Nat Biotechnol (2005) 5.80
Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis. Arch Neurol (2010) 4.03
In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. Circulation (2003) 4.00
Artificial reporter gene providing MRI contrast based on proton exchange. Nat Biotechnol (2007) 3.87
Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents. Radiology (2003) 3.71
High-resolution molecular structure of a peptide in an amyloid fibril determined by magic angle spinning NMR spectroscopy. Proc Natl Acad Sci U S A (2004) 3.58
Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction. Circulation (2005) 3.33
Strategic directions in tissue engineering. Tissue Eng (2007) 2.70
De novo determination of peptide structure with solid-state magic-angle spinning NMR spectroscopy. Proc Natl Acad Sci U S A (2002) 2.66
Feridex labeling of mesenchymal stem cells inhibits chondrogenesis but not adipogenesis or osteogenesis. NMR Biomed (2004) 2.54
Positive contrast visualization of iron oxide-labeled stem cells using inversion-recovery with ON-resonant water suppression (IRON). Magn Reson Med (2007) 2.49
New "multicolor" polypeptide diamagnetic chemical exchange saturation transfer (DIACEST) contrast agents for MRI. Magn Reson Med (2008) 2.48
The interaction of MS-325 with human serum albumin and its effect on proton relaxation rates. J Am Chem Soc (2002) 2.28
Multifunctional nanostructured materials for multimodal imaging, and simultaneous imaging and therapy. Chem Soc Rev (2008) 2.25
In vivo MR imaging of intravascularly injected magnetically labeled mesenchymal stem cells in rat kidney and liver. Radiology (2004) 2.22
Multifunctional uniform nanoparticles composed of a magnetite nanocrystal core and a mesoporous silica shell for magnetic resonance and fluorescence imaging and for drug delivery. Angew Chem Int Ed Engl (2008) 2.21
Development of a T1 contrast agent for magnetic resonance imaging using MnO nanoparticles. Angew Chem Int Ed Engl (2007) 2.19
Dual-modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia. Stroke (2008) 2.18
Synthesis of monodisperse spherical nanocrystals. Angew Chem Int Ed Engl (2007) 2.12
Magnetic resonance-guided, real-time targeted delivery and imaging of magnetocapsules immunoprotecting pancreatic islet cells. Nat Med (2007) 2.08
Tracking immune cells in vivo using magnetic resonance imaging. Nat Rev Immunol (2013) 2.05
Cellular MR imaging. Mol Imaging (2005) 2.01
Fluorocapsules for improved function, immunoprotection, and visualization of cellular therapeutics with MR, US, and CT imaging. Radiology (2010) 1.98
Using two chemical exchange saturation transfer magnetic resonance imaging contrast agents for molecular imaging studies. Acc Chem Res (2009) 1.95
Ultrasound-mediated tumor imaging and nanotherapy using drug loaded, block copolymer stabilized perfluorocarbon nanoemulsions. J Control Release (2011) 1.89
Nuts and bolts of chemical exchange saturation transfer MRI. NMR Biomed (2013) 1.88
Natural D-glucose as a biodegradable MRI contrast agent for detecting cancer. Magn Reson Med (2012) 1.84
Hot spot MRI emerges from the background. Nat Biotechnol (2005) 1.78
A nitric oxide signaling pathway controls CREB-mediated gene expression in neurons. Mol Cell (2006) 1.75
Tracking stem cells using magnetic nanoparticles. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2011) 1.73
Developing MR reporter genes: promises and pitfalls. NMR Biomed (2007) 1.70
Galvanic replacement reactions in metal oxide nanocrystals. Science (2013) 1.69
Sensitive CEST agents based on nucleic acid imino proton exchange: detection of poly(rU) and of a dendrimer-poly(rU) model for nucleic acid delivery and pharmacology. Magn Reson Med (2003) 1.68
Fabrication of hollow palladium spheres and their successful application to the recyclable heterogeneous catalyst for suzuki coupling reactions. J Am Chem Soc (2002) 1.63
Reversal of axonal loss and disability in a mouse model of progressive multiple sclerosis. J Clin Invest (2008) 1.61
Fluorine (19F) MRS and MRI in biomedicine. NMR Biomed (2010) 1.60
High-throughput screening of chemical exchange saturation transfer MR contrast agents. Contrast Media Mol Imaging (2010) 1.59
Use of stereolithography to manufacture critical-sized 3D biodegradable scaffolds for bone ingrowth. J Biomed Mater Res B Appl Biomater (2003) 1.59
Uniform mesoporous dye-doped silica nanoparticles decorated with multiple magnetite nanocrystals for simultaneous enhanced magnetic resonance imaging, fluorescence imaging, and drug delivery. J Am Chem Soc (2010) 1.58
Nuclear Overhauser enhancement (NOE) imaging in the human brain at 7T. Neuroimage (2013) 1.58
Designed synthesis of uniformly sized iron oxide nanoparticles for efficient magnetic resonance imaging contrast agents. Chem Soc Rev (2011) 1.57
Imaging of pancreatic islet cells. Diabetes Metab Res Rev (2011) 1.56
In vivo "hot spot" MR imaging of neural stem cells using fluorinated nanoparticles. Magn Reson Med (2008) 1.56
Intracytoplasmic tagging of cells with ferumoxides and transfection agent for cellular magnetic resonance imaging after cell transplantation: methods and techniques. Transplantation (2003) 1.55
Neural progenitor cell survival in mouse brain can be improved by co-transplantation of helper cells expressing bFGF under doxycycline control. Exp Neurol (2013) 1.54
Designed fabrication of multifunctional magnetic gold nanoshells and their application to magnetic resonance imaging and photothermal therapy. Angew Chem Int Ed Engl (2006) 1.54
MRI-detectable pH nanosensors incorporated into hydrogels for in vivo sensing of transplanted-cell viability. Nat Mater (2013) 1.53
Magnetic intracellular labeling of mammalian cells by combining (FDA-approved) superparamagnetic iron oxide MR contrast agents and commonly used transfection agents. Acad Radiol (2002) 1.53
In vivo bone regeneration using tubular perfusion system bioreactor cultured nanofibrous scaffolds. Tissue Eng Part A (2013) 1.53
Use of MR cell tracking to evaluate targeting of glial precursor cells to inflammatory tissue by exploiting the very late antigen-4 docking receptor. Radiology (2012) 1.51
Magnetic fluorescent delivery vehicle using uniform mesoporous silica spheres embedded with monodisperse magnetic and semiconductor nanocrystals. J Am Chem Soc (2006) 1.51
Magnetovaccination as a novel method to assess and quantify dendritic cell tumor antigen capture and delivery to lymph nodes. Cancer Res (2009) 1.49
Paramagnetic viral nanoparticles as potential high-relaxivity magnetic resonance contrast agents. Magn Reson Med (2005) 1.48
Effect of initial cell seeding density on early osteogenic signal expression of rat bone marrow stromal cells cultured on cross-linked poly(propylene fumarate) disks. Biomacromolecules (2009) 1.48
Generalized and facile synthesis of semiconducting metal sulfide nanocrystals. J Am Chem Soc (2003) 1.48
MR tracking of transplanted cells with "positive contrast" using manganese oxide nanoparticles. Magn Reson Med (2008) 1.46
Long-term MR cell tracking of neural stem cells grafted in immunocompetent versus immunodeficient mice reveals distinct differences in contrast between live and dead cells. Magn Reson Med (2010) 1.46
Large-scale synthesis of uniform and extremely small-sized iron oxide nanoparticles for high-resolution T1 magnetic resonance imaging contrast agents. J Am Chem Soc (2011) 1.45
One-nanometer-scale size-controlled synthesis of monodisperse magnetic iron oxide nanoparticles. Angew Chem Int Ed Engl (2005) 1.43
Sensitivity of magnetic resonance imaging of dendritic cells for in vivo tracking of cellular cancer vaccines. Int J Cancer (2007) 1.42
Ni/NiO core/shell nanoparticles for selective binding and magnetic separation of histidine-tagged proteins. J Am Chem Soc (2006) 1.42
Mesoporous silica-coated hollow manganese oxide nanoparticles as positive T1 contrast agents for labeling and MRI tracking of adipose-derived mesenchymal stem cells. J Am Chem Soc (2011) 1.41
Monitoring enzyme activity using a diamagnetic chemical exchange saturation transfer magnetic resonance imaging contrast agent. J Am Chem Soc (2011) 1.41
Multifunctional mesoporous silica nanocomposite nanoparticles for theranostic applications. Acc Chem Res (2011) 1.41
Bone tissue engineering bioreactors: dynamic culture and the influence of shear stress. Bone (2010) 1.40
Improved molecular imaging contrast agent for detection of human thrombus. Magn Reson Med (2003) 1.37
Wrap-bake-peel process for nanostructural transformation from beta-FeOOH nanorods to biocompatible iron oxide nanocapsules. Nat Mater (2008) 1.36
Noninvasive detection of macrophage-rich atherosclerotic plaque in hyperlipidemic rabbits using "positive contrast" magnetic resonance imaging. J Am Coll Cardiol (2008) 1.35
Chondrogenic differentiation of mesenchymal stem cells is inhibited after magnetic labeling with ferumoxides. Blood (2004) 1.35
Indirect detection of labile solute proton spectra via the water signal using frequency-labeled exchange (FLEX) transfer. J Am Chem Soc (2010) 1.35
Understanding proneurotrophin actions: Recent advances and challenges. Dev Neurobiol (2010) 1.35
Neuroprotection from stroke in the absence of MHCI or PirB. Neuron (2012) 1.33
A self-calibrating PARACEST MRI contrast agent that detects esterase enzyme activity. Contrast Media Mol Imaging (2010) 1.29
Improved pH measurements with a single PARACEST MRI contrast agent. Contrast Media Mol Imaging (2012) 1.28